SAN FRANCISCO, April 11, 2022 /PRNewswire/ -- The global continuous renal replacement therapy market size is anticipated to reach USD 2.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2022 to 2030. The primary driving factors for market growth are increasing prevalence of congestive heart failure and acute renal failure.
Key Insights & Findings from the report:
- By product, the consumables segment held the largest revenue share of 60.6% in 2021. Although these products are low-priced, it is used repeatedly purchased; hence the market for consumables is the largest as compared to other segments.
- Based on the modality, the Continuous Veno-venous Hemofiltration (CVVH) segment held the largest revenue share of 31.5% in 2021. Fluid overload situations, which are common in acute kidney injury patients in critical care units, are expected to increase, boosting the CVVH market's growth.
- Asia Pacific was the fastest growing market for continuous renal replacement therapy with a growth rate of 9.6%. Various factors are responsible for the region growth such as technological advancement, growing healthcare infrastructure development as well as and presence of such a huge patient base in this region.
Read 110-page market research report, "Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Product (System, Consumables), By Modality (Slow Continuous Ultra-Filtration, Continuous Veno-Venous Hemofiltration, By Region, And Segment Forecasts, 2022 - 2030", published by Grand View Research.
Continuous Renal Replacement Therapy Market Growth & Trends
The COVID-19 is expected to have a positive impact on market due to increasing prevalence of acute kidney injury. According to a WHO, acute kidney injury, a potentially life-threatening condition in which the kidneys cease working and uremic and fluid toxins build up in the body, is one of the many COVID-19 side effects. As a result, as the COVID-19 outbreak expands, demand for CRRT will continue to climb.
Over the forecast period, technological advancements are expected to be a crucial driver in the growth of the market. For example, in August 2020, Baxter International Inc., a global leader in acute care, announced that Regiocit, the company's replacement solution containing citrate for extracorporeal circuit regional citrate anticoagulation, has acquired an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA). Regiocit is exclusively approved for use as a replacement solution in adult patients receiving Continuous Renal Replacement Therapy (CRRT) and who require regional citrate anticoagulation during the COVID-19 pandemic, according to the EUA.
Continuous Renal Replacement Therapy Market Segmentation
Grand View Research has segmented the global continuous renal replacement therapy market on the basis of product, modality, and region:
Continuous Renal Replacement Therapy Product Outlook (Revenue, USD Million, 2017 - 2030)
- System
- Consumables
Continuous Renal Replacement Therapy Modality Outlook (Revenue, USD Million, 2017 - 2030)
- Slow continuous ultra-filtration (SCUF)
- Continuous veno-venous hemofiltration (CVVH)
- Continuous veno-venous hemodialysis (CVVHD)
- Continuous veno-venous hemodiafiltration (CVVHDF)
Continuous Renal Replacement Therapy Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
List of Key Players in Continuous Renal Replacement Therapy Market
- B. Braun Melsungen AG
- Baxter International, Inc.
- Fresenius Medical Care AG & Co. KGaA
- Asahi Kasei Corporation
- NIPRO Corporation
- Toray Medical Co., Ltd
- NxStage Medical, Inc.
- Medtronic plc & Others
Check out more related studies published by Grand View Research:
- U.S. Continuous Renal Replacement Therapy Market - The U.S. continuous renal replacement therapy market size is expected to reach USD 957.2 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.1% from 2021 to 2028.
- Wearable Artificial Kidney Market - The global wearable artificial kidney market size is anticipated to reach USD 7.7 billion by 2027. Increasing number of patients suffering from renal failure and technical advantages of artificial organs are anticipated to boost market growth.
- Nephrology And Urology Devices Market - The global nephrology and urology devices market size is anticipated to reach USD 7.21 billion by 2028 registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc.
Browse through Grand View Research's Medical Devices Industry Research Reports.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Grand View Compass | Grand View Pipeline
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
